
|Articles|June 15, 2017
Cenduit to Launch Quantum Interactive™ Solution at DIA 2017
Advertisement
Cenduit LLC, a joint venture between QuintilesIMS and Thermo Fisher Scientific, is showcasing its solutions as an interactive response technology (IRT) specialist at DIA next week, June 19-21, in Chicago. Same Osman, Cenduit's new CEO, will present at the show, and the company will launch its newest study build software, Quantum Interactive™.
Quantum Interactive is technology-based and increases IRT quality by creating a functioning prototype of an initial study build within minutes, according to the company. It is a user-friendly interface that guides the study building process for faster requirements discovery and is highly configurable, regardless of study design.
Read the full release
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Real-Time Evidence Generation, Protocol Digitization, and Decentralized Trial Flexibility
2
Achieving Clinical Trial Success with Three Key Elements of eCOA User Acceptance Testing
3
2026 DIA Global Annual Meeting: How Structured Protocols Enable Automated Amendments and Real-Time FDA Oversight
4
2026 DIA Global Annual Meeting: Stacy Hurt of Parexel on Federated AI, the Patient Voice, and Accountability for Patient Needs
5




